State Street Corporation 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 06:50 am Sale |
2024-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
STATE STREET CORP STT |
4,891,137 4.800% |
-257,156 (-4.99%) |
Filing |
| 2024-10-17 09:54 am Purchase |
2024-09-30 | 13G | Neurocrine Biosciences, Inc. NBIX |
STATE STREET CORP STT |
5,148,293 5.100% |
5,148,293 (New Position) |
Filing |